Intra-Cellular Therapies - 54 Year Dividend History | ITCI
Historical dividend payout and yield for Intra-Cellular Therapies (ITCI) since 1971. The current TTM dividend payout for Intra-Cellular Therapies (ITCI) as of January 31, 2025 is $0.00. The current dividend yield for Intra-Cellular Therapies as of January 31, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$13.466B |
$0.464B |
|
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
